Abliva AB (publ)
NEVPF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.13 | 0.01 | -0.05 |
| FCF Yield | 0.00% | -4.27% | -208.52% | -44.78% |
| EV / EBITDA | 0.00 | -1.66 | -0.14 | -1.94 |
| Quality | ||||
| ROIC | 0.00% | -135.70% | -50.47% | -297.36% |
| Gross Margin | 0.00% | -50,132.85% | -273,887.10% | -21,429.14% |
| Cash Conversion Ratio | 1.13 | 0.08 | 1.92 | 0.92 |
| Growth | ||||
| Revenue 3-Year CAGR | -3.19% | -47.64% | 4.06% | 250.88% |
| Free Cash Flow Growth | -1,044.16% | 94.33% | -39.34% | -66.99% |
| Safety | ||||
| Net Debt / EBITDA | 0.00 | 0.61 | 0.82 | 0.18 |
| Interest Coverage | 0.00 | -1,270.37 | -30.10 | -10,290.17 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 1.08 | 0.00 |
| Cash Conversion Cycle | 0.00 | 2,750.53 | -929,242.42 | 2,096.54 |